Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on X about a paper he co-authored with colleagues published in the Journal of Clinical Oncology:
“Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator’s Choice in Chemorefractory KRAS G12C Colorectal Cancer | Journal of Clinical Oncology.
Meaningful clinical benefits for KRAS G12C MCRC!”
Authors: Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, Dominik Paul Modest, David Paez Lopez-Bravo, Emily Chan, Joseph Chao, Qui Tran, Chiara Cremolini, Marwan Fakih et al.
More posts featuring Marwan Fakih.